Figure 5
From: HER4 in breast cancer: comparison of antibodies against intra- and extra-cellular domains of HER4
Cumulative survival differences between patients positive or negative for nuclear HER4 using the H4.77.16 antibody. Kaplan-Meier survival curves demonstrating cumulative survival differences (endpoint breast cancer related death) between patients positive or negative for nuclear (nuc) HER4 using the H4.77.16 antibody. P values represent log rank testing of the difference in cumulative disease free survival.